Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on April 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Hyperspectral Imaging Microscope System Integration

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract entails the full integration of a custom upright microscope into a fully functional hyperspectral imaging platform, requiring seamless coordination of motorized stages, precision illumination systems, high-resolution cameras, and automated autofocus mechanisms to ensure accurate and repeatable hyperspectral data collection. All components must be synchronized and calibrated to operate as a unified system, meeting stringent performance standards for scientific imaging applications. The integration must support advanced spectral analysis capabilities and be optimized for use in research and diagnostic environments. The contract is a subcontract under the FDA Office of Acquisition and Grant Services, part of the Department of Health and Human Services, with performance obligated at Silver Spring, Maryland, zip code 20993. It is classified under NAICS code 333318 for scientific and medical instrument manufacturing. The opportunity was posted on April 23, 2026, with a response deadline of April 30, 2026, at 6:00 PM Eastern Time. While no set-aside designation is specified, the contract is structured to engage qualified subcontractors capable of delivering a complex, multi-system engineering solution with high technical precision and reliability.

General Info

Integrate custom microscope into hyperspectral imaging platform for FDA in Silver Spring, Maryland, meeting high-precision scientific standards.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

333318 - Other Commercial and Service Industry Machinery ManufacturingView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Documents

This scope was carved out of CDRH-2026-134025.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Purchase of Optical Microscope

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Full integration of a custom upright microscope configured as a hyperspectral imaging platform, including motorized stages, illumination, camera, and autofocus systems.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human induced pluripotent stem cell (iPSC)-derived hindbrain organoid functional assay services. The project aims to support in vitro research evaluating drug-induced effects on respiratory-relevant neural circuits over an eighteen-month period of performance. The scope of work is divided into two primary components: the provision of human hindbrain organoids and associated culture materials through twelve scheduled deliveries to the FDA White Oak Campus, and the performance of functional characterization services at the contractor's laboratory. Functional characterization will utilize three-dimensional multi-electrode array (3D MEA) technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Deliverables include the delivery of 96 organoids in the first shipment followed by 48 organoids in subsequent deliveries, as well as raw data, analyzed data, analysis files, and comprehensive study reports. This acquisition is conducted as a commercial service under FAR Part 12, with the government restricting competition based on market research identifying OrganoTherapeutics SARL as the only source capable of meeting the complete requirement for both the specific organoid products and the associated functional assay services.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 13 hours ago

DEADLINE

in 6 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS